Literature DB >> 10841815

Gatekeeper for endometrium: the PTEN tumor suppressor gene.

I U Ali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10841815     DOI： 10.1093/jnci/92.11.861

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  17 in total

1.  Pten, a protean tumor suppressor.

Authors:  G L Mutter
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA.

Authors:  Frank Czauderna; Melanie Fechtner; Hüseyin Aygün; Wolfgang Arnold; Anke Klippel; Klaus Giese; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

3.  Endometrial cancer.

Authors:  Kimberly K Leslie; Kristina W Thiel; Michael J Goodheart; Koen De Geest; Yichen Jia; Shujie Yang
Journal:  Obstet Gynecol Clin North Am       Date:  2012-06       Impact factor: 2.844

Review 4.  PTEN in DNA damage repair.

Authors:  Mei Ming; Yu-Ying He
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

5.  Has the time come to include low-level laser photobiomodulation as an adjuvant therapy in the treatment of impaired endometrial receptivity?

Authors:  Doaa Abdelmageed El Faham; Mohamed Amr Hussein Elnoury; Mona Ibraheim Morsy; Marwa Abdelmoneim El Shaer; Ghada Mohammed Nour Eldin; Osama Mahmoud Azmy
Journal:  Lasers Med Sci       Date:  2018-03-15       Impact factor: 3.161

6.  Diagnosis of premalignant endometrial disease.

Authors:  G L Mutter
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

7.  Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance.

Authors:  Jennifer D Cook; Barbara J Davis; Sheng-Li Cai; J Carl Barrett; Claudio J Conti; Cheryl Lyn Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

8.  Considerations when analyzing the methylation status of PTEN tumor suppressor gene.

Authors:  Michele A Zysman; William B Chapman; Bharati Bapat
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

9.  Germline mutations and polymorphisms in the origins of cancers in women.

Authors:  Kim M Hirshfield; Timothy R Rebbeck; Arnold J Levine
Journal:  J Oncol       Date:  2010-01-10       Impact factor: 4.375

Review 10.  Genetic modelling of the PTEN/AKT pathway in cancer research.

Authors:  Oliver Renner; Carmen Blanco-Aparicio; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.